Effect of antioxidant vitamin supplementation on erythrocyte membrane composition in type I diabetes mellitus in context of oxidative stress

Biomedical Research

Volumn 21, Issue 2, 2010, Pages 156-160

  Shinde, Sarita A ^a   Suryakar, Adinath N ^b   Sontakke, Alka N ^a   More, Umesh K ^a  

^a HOSPITAL AND RESEARCH CENTRE   (India)

^b Dr Vaishampayan Memorial Medical College   (India)

Author keywords

Diabetes mellitus; Membrane cholesterol; Oxidative stress; Phospholipids; Vitamin E and C

Indexed keywords

ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; CHOLESTEROL; EVINAL; GLUTATHIONE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LONG ACTING INSULIN; MALONALDEHYDE; PHOSPHOLIPID; SHORT ACTING DRUG; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CELL PROTECTION; CELL STRESS; CONTROLLED STUDY; ERYTHROCYTE DISORDER; ERYTHROCYTE MEMBRANE; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MEMBRANE COMPONENT; OXIDATIVE STRESS; PHOSPHOLIPID MEMBRANE; VITAMIN SUPPLEMENTATION;

EID: 77956247375     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Braunwald B, Longo FH, Jameson. Diabetes mellitus in Harrison's principles of internal medicine, 17th Ed, Mc Graw-Hill publication, I: 2005; 1463-1464
2. Emily H, Tammy MB. Antioxidants, NFKB Activation and Diabetogenesis. Expt Biol Med 1999; 222: 205-213.
3. Biswas BR. Occular complication of diabetes mellitus. The journal of general medicine. 2002; 14: 21-27.
4. Scwartz RS, Madsen JW, Anne C, Raybicky, Nagel RL. Oxidation of spectrin and deformability defects in diabetic erythrocytes. Diabetes 1991; 40: 701-708.
5. Resm H, Peketin C, Guner G. Erythrocyte membrane cytoskeletol protein glycation and oxidation in short term diabetic rabbits. Clin. Exp. Med 2001; 1: 187-193.
6. Constantinescu A, Derick H, Packer L. Vitamin E recy-cling in human erythrocyte membranes. The journal of biological chemistry 1993; 268 (15): 10906-10913.
7. Selvam R. Anuradha CV. Lipid peroxidation and anti-peroxidative enzymes changes in erythrocytes in diabe-tes mellitus. Indian J Biochem Biophysics 1988; 25: 268-272.
8. Baynes JW. The role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-411.
9. Trinder P. Estimation of blood sugar level by GOD-POD method. Ann. Clin Biochem 1969; 6: 24-24.
10. Trivelli LA, Ranney PH, Lai HT. Estimation of gly-cated hemoglobin by resin binding method. New Eng J Med 197; 284: 353-353.
11. Fairbanks V, George K. Biochemical aspects of hema-tology in Teitz Text Book of Clinical Chemistry editors Carl Burtis and Edward Ashwood 3rd edn. WB Saun-ders Co Philadelphia: PA 1999; 1652-1653.
12. Wilbur KM, Bernheim F, Shapiro OW. The thiobarbi-turic acid method for mlaondialdehyde estimation. Arch Biochem Biophy 1943; 250; 305-313.
13. Dodge JT, Mitcheli C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin free ghosts of human erythrocytes. Archives of biochemistry and biophysics 196; 100: 119-130.
14. The colorimetric estimation of serum choles-terol. Am. J. Clin Pathol 1957: 27: 583-585
15. Varley H, Gowenlock AH and Bell M. Practical clinical biochemistry. 4th Edn.William Heinemann Medical Book Ltd. London 1976; 473-474
16. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem1951; 193: 265-275.
17. McMillan DE. Plasma protein changes, blood viscosity and diabetic microangiopathy. Diabetes 1976; 25 suppl 2): 858-864.
18. Schut NH, Van Arkel EC, Hardeman MR, Bilo HJG, Michels RPJ, Vreekan J. Blood and plasma viscosity in diabetes: possible contribution to late organ com-plications? Diabetes Res 1992; 19: 31-35.
19. Nagle JF and Tristram- Nagle S. Structure of lipid bi-layers. Biochim Biophys Acta 2000; 1469: 159-195.
20. Ellenberg M, Rifkin H. Diabetes mellitus theory and practice. 3rd Edn. New York: Medical examination Publishing Co. 1983.
21. Watala C, Pluta J, Golanski J. Increased protein glyca-tion in diabetes mellitus is associated with decreased aspirin- mediated protein acetylation and reduced sensi-tivity of blood platelets to aspirin. J Mol Med 2005; 83: 148-158.
22. Ceriello. A hyperglycemia: the bridge between non enzymatic glycation and oxidative stress in the patho-genesis of diabetic complications. Diabetes Nut Metab 1999; 12(1): 42-46.
23. May J. Is ascorbic acid an antioxidant for the plasma membrane? FASEB 1999; 13: 995-1006.
24. Murray RK, Keeley FW. Micronutrients and vitamins In: Murray RK, Granner DK, Mayes PA, Rodwell VW, Harper's illustrated biochemistry, 27th Edn. Lange medical Books, Mc Graw hill (2006); 494-495
25. Chiu D, Lubin B, Shonet S. Erythrocyte membrane lipid reorganization during sickling process. Br J Hae-matol 1979; 41: 223-234.
26. Haest CWM, Plasa G, Kamp D, Deuticke B. Spectrin as astabilizer of the phospholipid asymmetry in the human erythrocyte membrane. Biochem Biophys Acta 1978: 509: 21-32.
27. Ricther C. Biophysical consequences of lipid-peroxida-tion in membranes. Chem Phys Lipids 1987: 44: 175 -189.
28. Lubin B, Chiu D, Bastaky J, Roelafsen B, Van Deenen LLM. Oxidative hemoglobin denaturation and RBC de-struction. Semin Haematol 1989: 26: 128-135.